English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/162119
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1

AuthorsGigante, Alba ; Gómez-SanJuan, Asier; Delang, Leen; Li, C.; Bueno, Oskía; Gamo, Ana María ; Priego, Eva María ; Camarasa Rius, María José ; Jochmans, D.; Leyssen, Pieter; Decroly, E.; Coutard, Bruno; Querat, Guilles; Neyts, Johan; Peréz-Pérez, María-Jesús
KeywordsOximes
Chikungunya virus
Alphavirus
mRNA capping
Triazolopyrimidines
Issue Date2017
PublisherElsevier
CitationAntiviral Research 144: 216-222 (2017)
AbstractChikungunya virus (CHIKV) is a re-emerging alphavirus transmitted to humans by Aedes mosquitoes. Since 2005, CHIKV has been spreading worldwide resulting in epidemics in Africa, the Indian Ocean islands, Asia and more recently in the Americas. CHIKV is thus considered as a global health concern. There is no specific vaccine or drug available for the treatment of this incapacitating viral infection. We previously identified 3-aryl-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as selective inhibitors of CHIKV replication and proposed the viral capping enzyme nsP1 as a target. This work describes the synthesis of novel series of related compounds carrying at the aryl moiety a methylketone and related oximes combined with an ethyl or an ethyl-mimic at 5-position of the triazolopyrimidinone. These compounds have shown antiviral activity against different CHIKV isolates in the very low μM range based on both virus yield reduction and virus-induced cell-killing inhibition assays. Moreover, these antivirals inhibit the in vitro guanylylation of alphavirus nsP1, as determined by Western blot using an anti-cap antibody. Thus, the data obtained seem to indicate that the anti-CHIKV activity might be related to the inhibition of this crucial step in the viral RNA capping machinery.
Publisher version (URL)http://dx.doi.org/10.1016/j.antiviral.2017.06.003
URIhttp://hdl.handle.net/10261/162119
Identifiersdoi: 10.1016/j.antiviral.2017.06.003
issn: 0166-3542
e-issn: 1872-9096
Appears in Collections:(IQM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.